Sixty one subjects received 5ml solution contained 0.25 % ropivacaine plus 5mg/kg magnesium sulphate ( Group M+R ) , 5ml 0.25 % ropivacaine ( Group R ) or 5ml solution contained 5mg/kg magnesium sulphate ( Group M ) .